• Je něco špatně v tomto záznamu ?

WAA apheresis registry in the Czech Republic: two centers experience

M. Blaha, J. Ptak, J. Cap, V. Ceeova, V. Masin, S. Filip, M. Blazek

. 2009 ; 41 (1) : 27-31.

Jazyk angličtina Země Velká Británie

Typ dokumentu multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12009174

Grantová podpora
NR9181 MZ0 CEP - Centrální evidence projektů
NR9103 MZ0 CEP - Centrální evidence projektů

INTRODUCTION: Hemaphereses are sophisticated procedures performed for many indications even in severely ill patients. Many authors consider quite necessary to register as many details as possible of treatments with therapeutic apheresis. WAA meets the requirement to compare data with centers not performing apheresis for the same diagnosis. In Czech Republic hemaphereses are used in a broad spectrum of indications. Since the year 2004 data on hemaphereses done in Czech Republic have been registered. In this paper we present a survey of our to date recordings. PATIENTS AND METHODS: Data of performed therapeutic hemaphereses (plasma exchange, erythrocytapheresis, leukapheresis, thrombocytapheresis, photopheresis, immunopheresis, and rheopheresis) have been entered in WAA registry with many details. We have been evaluated 1289 procedures in 216 patients done in our two centers (center I, center II). RESULTS: Center I registered 129 procedures in 41 patients, center II 1260 procedures in 175 patients. The patients are divided according to centers specialization (center II has registered 12 long-term treated patients with LDL-apheresis; mean time of therapy 7.1 years and a median of 34 procedures/patient. Side-effects registered in center I and center II were 3.1% and 5.6% of the procedures, respectively. Most frequent side-effects were citrate toxicity, neurovegetative lability, problems with venous access and hypotension. All were easy to treat, no serious events or death occurred. CONCLUSIONS: In Czech Republic hemaphereses are performed in a broad scale of indications and now it is nearly 5 years that data are registered in our two university centers. In 2004 we entered WAA registry because it meets the requirement to compare data with centers that do not perform aphereses for the same diagnosis. This comparison would certainly improve efficacy of the hemapheresis therapy even further. To enter WAA registry is easy, at no expense and without any problems.

000      
03978naa a2200565 a 4500
001      
bmc12009174
003      
CZ-PrNML
005      
20140407150601.0
008      
120319s2009 xxk eng||
009      
AR
040    __
$d ABA008 $a ABA008 $b cze
041    0_
$a eng
044    __
$a xxk
100    1_
$a Bláha, Milan, $d 1938- $7 xx0034440 $u Faculty of Medicine and Faculty Hospital, Charles University, Hradec Kralove, Czech Republic. blaha@fnhk.cz
245    10
$a WAA apheresis registry in the Czech Republic: two centers experience $c M. Blaha, J. Ptak, J. Cap, V. Ceeova, V. Masin, S. Filip, M. Blazek
520    9_
$a INTRODUCTION: Hemaphereses are sophisticated procedures performed for many indications even in severely ill patients. Many authors consider quite necessary to register as many details as possible of treatments with therapeutic apheresis. WAA meets the requirement to compare data with centers not performing apheresis for the same diagnosis. In Czech Republic hemaphereses are used in a broad spectrum of indications. Since the year 2004 data on hemaphereses done in Czech Republic have been registered. In this paper we present a survey of our to date recordings. PATIENTS AND METHODS: Data of performed therapeutic hemaphereses (plasma exchange, erythrocytapheresis, leukapheresis, thrombocytapheresis, photopheresis, immunopheresis, and rheopheresis) have been entered in WAA registry with many details. We have been evaluated 1289 procedures in 216 patients done in our two centers (center I, center II). RESULTS: Center I registered 129 procedures in 41 patients, center II 1260 procedures in 175 patients. The patients are divided according to centers specialization (center II has registered 12 long-term treated patients with LDL-apheresis; mean time of therapy 7.1 years and a median of 34 procedures/patient. Side-effects registered in center I and center II were 3.1% and 5.6% of the procedures, respectively. Most frequent side-effects were citrate toxicity, neurovegetative lability, problems with venous access and hypotension. All were easy to treat, no serious events or death occurred. CONCLUSIONS: In Czech Republic hemaphereses are performed in a broad scale of indications and now it is nearly 5 years that data are registered in our two university centers. In 2004 we entered WAA registry because it meets the requirement to compare data with centers that do not perform aphereses for the same diagnosis. This comparison would certainly improve efficacy of the hemapheresis therapy even further. To enter WAA registry is easy, at no expense and without any problems.
590    __
$a bohemika - dle Pubmed
650    02
$a dospělí $7 D000328
650    02
$a separace krevních složek $x metody $x statistika a číselné údaje $x škodlivé účinky $7 D001781
650    02
$a transfuze erytrocytů $7 D017707
650    02
$a ženské pohlaví $7 D005260
650    02
$a lidé $7 D006801
650    02
$a hypercholesterolemie $x terapie $7 D006937
650    02
$a transfuze leukocytů $7 D017708
650    02
$a mužské pohlaví $7 D008297
650    02
$a lidé středního věku $7 D008875
650    02
$a fotoferéza $7 D017893
650    02
$a výměna plazmy $x statistika a číselné údaje $7 D010951
650    02
$a plazmaferéza $x metody $x statistika a číselné údaje $x škodlivé účinky $7 D010956
650    02
$a transfuze trombocytů $7 D017713
650    02
$a trombocytaferéza $7 D010983
650    02
$a registrace $x statistika a číselné údaje $7 D012042
650    02
$a mladý dospělý $7 D055815
651    _2
$a Česká republika $7 D018153
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pták, Jan, $d 1950- $7 xx0034439
700    1_
$a Čáp, Jan, $d 1953- $7 mzk2003190513
700    1_
$a Ceeová, Věra $7 xx0142514
700    1_
$a Mašín, Vladimír $7 xx0061146
700    1_
$a Filip, Stanislav, $d 1961- $7 jn20010309153
700    1_
$a Blažek, Martin, $d 1973- $7 xx0052609
773    0_
$t Transfusion & Apheresis Science $p Transfus Apheresis Sci $g Roč. 41, č. 1 (2009), s. 27-31 $x 1473-0502 $w MED00008583
773    0_
$p Transfus Apheresis Sci $g 41(1):27-31, 2009 Aug $x 1473-0502
910    __
$a ABA008 $b x $y 4 $z 0
990    __
$a 20120319150917 $b ABA008
991    __
$a 20140407150648 $b ABA008
999    __
$a ok $b bmc $g 902397 $s 766080
BAS    __
$a 3
BMC    __
$a 2009 $b 41 $c 1 $d 27-31 $i 1473-0502 $m Transfusion and apheresis science $x MED00008583
GRA    __
$a NR9181 $p MZ0
GRA    __
$a NR9103 $p MZ0
LZP    __
$a 2012-1Q10/jj

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...